{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:20:18Z","timestamp":1790612418787,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.dsx.2020.06.015","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T21:04:12Z","timestamp":1591823052000},"page":"829-831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?"],"prefix":"10.1016","volume":"14","author":[{"given":"Mukherjee","family":"Jagat J","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangopadhyay","family":"Kalyan K","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Subir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2020.06.015_bib1","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","author":"Zhang","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.dsx.2020.06.015_bib2","first-page":"603409","article-title":"Pioglitazone upregulated angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced non-alcoholic steatohepatitis","author":"Zhang","year":"2014","journal-title":"Sci World J"},{"key":"10.1016\/j.dsx.2020.06.015_bib3","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibitor and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2020.06.015_bib4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.dsx.2020.06.015_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/CIRCHEARTFAILURE.108.840124","article-title":"Loss of angiotensin-converting enzyme 2 accelerated maladaptive left ventricular remodelling in response to myocardial infarction","volume":"2","author":"Kassiri","year":"2009","journal-title":"Circ Hart Fail"},{"issue":"5","key":"10.1016\/j.dsx.2020.06.015_bib6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4103\/ijmr.IJMR_650_15","article-title":"Pioglitazone utilization, efficacy & safety in Indian type 2 diabetic patients: a systematic review & comparison with European Medicines Agency Assessment Report","volume":"144","author":"Pai","year":"2016","journal-title":"Indian J Med Res"},{"issue":"4","key":"10.1016\/j.dsx.2020.06.015_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.dsx.2020.06.015_bib8","series-title":"Effect of hyperglycemia and thiazolidinediones on cardiac angiotensin converting enzyme 2 (ACE2) and neprilysin (NEP) in db\/db diabetic mice","author":"Fadnavis","year":"2017"},{"key":"10.1016\/j.dsx.2020.06.015_bib9","doi-asserted-by":"crossref","unstructured":"Canrong Wu, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y et\u00a0al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B https:\/\/doi.org\/10.1016\/j.apsb.2020.02.008","DOI":"10.1016\/j.apsb.2020.02.008"},{"key":"10.1016\/j.dsx.2020.06.015_bib10","article-title":"Liraglutide enhances the activity of the ACE2\/Ang(1-7) Mas receptor pathway in lungs of male pups from food-restricted mothers and prevents the reduction of SP-A","author":"Fandino","year":"2018","journal-title":"Internet J Endocrinol"},{"key":"10.1016\/j.dsx.2020.06.015_bib11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/vim.2010.0016","article-title":"PPAR-gamma activation as an anti-inflammatory therapy for respiratory virus infections","volume":"23","author":"Bassaganya-Riera","year":"2010","journal-title":"Viral Immunol"},{"issue":"13","key":"10.1016\/j.dsx.2020.06.015_bib12","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood-2010-08-302224","article-title":"Regulation of dectin-1 mediated dendritic cell activation by peroxisome proliferator-activated receptor-gamma ligand troglitazone","volume":"117","author":"Kock","year":"2011","journal-title":"Blood."},{"key":"10.1016\/j.dsx.2020.06.015_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jss.2014.03.007","article-title":"Pioglitazone attenuates lung injury by modulating adipose inflammation","volume":"189","author":"Kutsukake","year":"2014","journal-title":"J\u00a0Surg Res"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120301843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120301843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:15:57Z","timestamp":1761729357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402120301843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1871402120301843"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2020.06.015","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2020.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}